C3P3 artificial expression system for innovative synthetic gene therapy and bioproduction tools

 

Eukarÿs is a front runner in eukaryotic artificial expression system and its breakthrough applications: synthetic gene therapy – a radically novel, sure and effective therapeutic approach for the treatment of human disorders – and innovative solutions for bioproduction of recombinant proteins and viruses

Eukarÿs C3P3 technology is the first ever non-viral artificial expression system that synthesizes in the cytoplasm of cells the messenger RNAs or inhibitory RNAs of interest in any eukaryotic cells. For further information on the C3P3 technology or its applications, click on the boxes below

Eukarÿs SAS – Génopole campus

4 rue Pierre Fontaine

921058 Evry Cedex

France